VANCOUVER, Oct. 3 /CNW/ - The Vertex Fund ("Vertex") announces that it
has acquired 3,097,874 common shares of CryoCath Technologies Inc.
("CryoCath") representing approximately 7.256% of the issued and outstanding
common shares of CryoCath and the Vertex Offshore Fund, Ltd. ("Vertex
Offshore") announces that it has acquired 32,126 common shares of CryoCath
representing approximately 0.075% of the issued and outstanding common shares
of CryoCath. As a result of the acquisition of such shares, Vertex, together
with Vertex Offshore, own a total of 3,130,000 common shares, representing
approximately 7.33% of the issued and outstanding common shares of CryoCath.
The common shares were purchased by Vertex and Vertex Offshore in the
open market on the Toronto Stock Exchange. Vertex and Vertex Offshore acquired
the securities for investment purposes only and may, depending on market and
other conditions, increase or decrease their beneficial ownership, control or
direction over common shares or other securities of CryoCath through market
transactions, private agreements or otherwise.
This press release is being issued pursuant to section 5.3 of
Multilateral Instrument 62-104 of the Canadian Securities Administrators.
VERTEX FUND and the VERTEX OFFSHORE FUND, LTD.
by their Manager VERTEX ONE ASSET MANAGEMENT INC.
(signed) "Jeff McCord"
For further information:
For further information: Jeff McCord, (604) 681-5787